Caplin Point Laboratories has received Colombia's INVIMA approval for its small volume sterile injectable division at Puducherry. The site inspection of Unit-1 was completed on May 10 and found compliant as per INVIMA's norms of Good Manufacturing Practices (GMP) and Good Laboratory Practices (GLP). The facility is capable of manufacturing Liquid injectables in Vials, Ampoules, Lyophilized Vials and Pre-Filled Syringes, amongst other dosage forms.
Caplin Point Laboratories is engaged mainly in manufacturing a wide range of Ointments, Creams and other External application preparations in addition to the regular segments of pharmaceutical formulations.
